LIVE WEBINAR

The Use of Automated Insulin Delivery (AID) Systems in Pregnancy    

     

OVERVIEW

ADA Member Exclusive Webinar—This session will explore the benefits and limitations of using automated insulin delivery (AID) systems during pregnancy for individuals with Type 1 diabetes, including impacts on glycemic outcomes, patient burdens, and system-specific constraints. The panel will also review glucose targets across different AID systems, examine which user inputs most influence insulin delivery, and discuss clinical trial protocols designed to achieve stringent pregnancy glucose targets. The webinar will conclude with a live Q&A session, offering participants the opportunity to engage directly with the experts. 

LEARNING OBJECTIVES

Evaluate the benefits and limitations of automated insulin delivery (AID) system use during pregnancy in individuals with Type 1 diabetes, including glycemic outcomes, patient burden, and system-specific constraints.  

 

Identify the glucose targets used by different AID systems and understand which user inputs have the most influence on insulin delivery.  

 

Understand the protocols used in AID clinical trials aimed at achieving stringent pregnancy glucose targets. 

BENEFITS

1 CE Credit

DATE & TIME

April 8, 2026; 2:00–3:00 p.m. ET

EXPIRATION DATE

December 31, 2026

SPEAKERS

Carol J Levy, MD, CDCES
Professor in the Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, and a Professor in the Department of Obstetrics, Gynecology and Reproductive Science

Icahn School of Medicine at Mount Sinai

New York, New York

Grenye O’Malley, MD 

Assistant Professor of Medicine

 Icahn School of Medicine at Mount Sinai 

New York, New York 

MODERATOR

Anyanate Gwendolyne Jack, MD

Assistant Professor of Clinical Medicine 
New York Presbyterian-Weill Cornell Medicine 

New York, New York 

Android App Download IOS App Download Powered By